Cite
The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
MLA
Chen, Yi-Ming, et al. “The Effects of Rituximab Therapy on Released Interferon-γ Levels in the QuantiFERON Assay among RA Patients with Different Status of Mycobacterium Tuberculosis Infection.” Rheumatology, vol. 52, no. 4, Apr. 2013, pp. 697–704. EBSCOhost, https://doi.org/10.1093/rheumatology/kes365.
APA
Chen, Y.-M., Chen, H.-H., Lai, K.-L., Hung, W.-T., Lan, J.-L., & Chen, D.-Y. (2013). The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection. Rheumatology, 52(4), 697–704. https://doi.org/10.1093/rheumatology/kes365
Chicago
Chen, Yi-Ming, Hsin-Hua Chen, Kuo-Lung Lai, Wei-Ting Hung, Joung-Liang Lan, and Der-Yuan Chen. 2013. “The Effects of Rituximab Therapy on Released Interferon-γ Levels in the QuantiFERON Assay among RA Patients with Different Status of Mycobacterium Tuberculosis Infection.” Rheumatology 52 (4): 697–704. doi:10.1093/rheumatology/kes365.